Preparation and evaluation of bicyclol microemulsions for enhanced oral bioavailability

References

• Tan W, Chen H, Zhao J, Hu J, Li Y. (2008). A study of intestinal absorption of bicyclol in rats: active efflux transport and metabolism as causes of its poor bioavailability. J Pharm Pharm Sci, 11:97–105.
   PubMed Web of Science ®Google Scholar
• Sheng L, Hu J, Wang B, Chen H, Li Y. (2010). Determination of bicyclol in dog plasma using liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci, 878:2106–2110.
   PubMed Web of Science ®Google Scholar
• Liu GT. (2001). The anti-virus and hepatoprotective effect of bicyclol and its mechanism of action. Zhongguo Xinyao Zazhi 10:325–327.
   Google Scholar
• Li Y, Dai GW, Li Y, Liu GT. (2001). [Effect of bicyclol on acetaminophen-induced hepatotoxicity: energetic metabolism and mitochondrial injury in acetaminophen-intoxicated mice]. Yao Xue Xue Bao, 36:723–726.
   PubMedGoogle Scholar
• Gu XJ. (2004). The efficacy of bicyclol in treatment of chronic hepatitis B. Zhongguo Xinyao Zazhi 13:940–942.
   Google Scholar
• Liu YH, Han ZM. (2011). [Effects of bicyclol on renal PAI-1 expression in rats with uniliteral ureteral obstruction]. Zhongguo Dang Dai Er Ke Za Zhi, 13:509–513.
   PubMedGoogle Scholar
• Ru XC, Liang KY, Lei WH, Tan YN, Xia Q. (2011). [Bicyclol protects rat thoracic aorta from superoxide anion-induced inhibition of vascular relaxation]. Zhongguo Ying Yong Sheng Li Xue Za Zhi, 27:81–85.
   PubMedGoogle Scholar
• Luo Y, Zhang B, Xu DQ, Liu Y, Dong MQ, Zhao PT et al. (2011). Protective effect of bicyclol on lipopolysaccharide-induced acute lung injury in mice. Pulm Pharmacol Ther, 24:240–246.
   PubMed Web of Science ®Google Scholar
• Zhao D, Liu G. (2001). [Protective effect of bicyclol on concanavalin A-induced liver nuclear DNA injury in mice]. Zhonghua Yi Xue Za Zhi, 81:844–848.
   PubMedGoogle Scholar
• Liu GT. (2009). Bicyclol: a novel drug for treating chronic viral hepatitis B and C. Med Chem, 5:29–43.
   PubMed Web of Science ®Google Scholar
• Liu GT, Li Y, Wei HL, Lu H, Zhang H, Gao YG et al. (2005). Toxicity of novel anti-hepatitis drug bicyclol: a preclinical study. World J Gastroenterol, 11:665–671.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Yoon KA, Hahn M, Park ES, Chi SC. (2000). Preparation and in vitro evaluation of self-microemulsifying drug delivery systems containing idebenone. Drug Dev Ind Pharm, 26:523–529.
   PubMed Web of Science ®Google Scholar
• Yong CS, Park BJ, Kim DH, Yoo BK, Woo JS, Bhamdari K et al. (2007). Short communication: in vivo evaluation of microemulsion system for oral and parenteral delivery of rutaecarpine to rats. Drug Dev Ind Pharm, 33:531–534.
   PubMed Web of Science ®Google Scholar
• Cui J, Yu B, Zhao Y, Zhu W, Li H, Lou H et al. (2009). Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int J Pharm, 371:148–155.
   PubMed Web of Science ®Google Scholar
• Hirunpanich V, Sato H. (2009). Improvement of cyclosporine A bioavailability by incorporating ethyl docosahexaenoate in the microemulsion as an oil excipient. Eur J Pharm Biopharm, 73:247–252.
   PubMed Web of Science ®Google Scholar
• Patel D, Sawant KK. (2009). Self micro-emulsifying drug delivery system: formulation development and biopharmaceutical evaluation of lipophilic drugs. Curr Drug Deliv, 6:419–424.
   PubMedGoogle Scholar
• Singh AK, Chaurasiya A, Awasthi A, Mishra G, Asati D, Khar RK et al. (2009). Oral bioavailability enhancement of exemestane from self-microemulsifying drug delivery system (SMEDDS). AAPS PharmSciTech, 10:906–916.
   PubMed Web of Science ®Google Scholar
• Wu H, Lu C, Zhou A, Min Z, Zhang Y. (2009). Enhanced oral bioavailability of puerarin using microemulsion vehicle. Drug Dev Ind Pharm, 35:138–144.
   PubMed Web of Science ®Google Scholar
• Yin YM, Cui FD, Mu CF, Choi MK, Kim JS, Chung SJ et al. (2009). Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation. J Cont Rel, 140:86–94.
   PubMed Web of Science ®Google Scholar
• Attivi D, Ajana I, Astier A, Demoré B, Gibaud S. (2010). Development of microemulsion of mitotane for improvement of oral bioavailability. Drug Dev Ind Pharm, 36:421–427.
   PubMed Web of Science ®Google Scholar
• Dixit AR, Rajput SJ, Patel SG. (2010). Preparation and bioavailability assessment of SMEDDS containing valsartan. AAPS PharmSciTech, 11:314–321.
   PubMed Web of Science ®Google Scholar
• He CX, He ZG, Gao JQ. (2010). Microemulsions as drug delivery systems to improve the solubility and the bioavailability of poorly water-soluble drugs. Expert Opin Drug Deliv, 7:445–460.
   PubMed Web of Science ®Google Scholar
• Venkatesh G, Majid MI, Mansor SM, Nair NK, Croft SL, Navaratnam V. (2010). In vitro and in vivo evaluation of self-microemulsifying drug delivery system of buparvaquone. Drug Dev Ind Pharm, 36:735–745.
   PubMed Web of Science ®Google Scholar
• Dong X, Ke X, Liao Z. (2011). The microstructure characterization of meloxicam microemulsion and its influence on the solubilization capacity. Drug Dev Ind Pharm, 37:894–900.
   PubMed Web of Science ®Google Scholar
• Hu L, Wu H, Niu F, Yan C, Yang X, Jia Y. (2011). Design of fenofibrate microemulsion for improved bioavailability. Int J Pharm, 420:251–255.
   PubMed Web of Science ®Google Scholar
• Mezghrani O, Ke X, Bourkaib N, Xu BH. (2011). Optimized self-microemulsifying drug delivery systems (SMEDDS) for enhanced oral bioavailability of astilbin. Pharmazie, 66:754–760.
   PubMed Web of Science ®Google Scholar
• Wu X, Xu J, Huang X, Wen C. (2011). Self-microemulsifying drug delivery system improves curcumin dissolution and bioavailability. Drug Dev Ind Pharm, 37:15–23.
   PubMed Web of Science ®Google Scholar
• Kim CK, Cho YJ, Gao ZG. (2001). Preparation and evaluation of biphenyl dimethyl dicarboxylate microemulsions for oral delivery. J Cont Rel, 70:149–155.
   PubMed Web of Science ®Google Scholar
• Woo JS, Jung WT, Kim AG, Yoo TS, Kim MS, Hwang MS. (2004). Microemulsion composition for oral administration of biphenyldimethyldicarboxylate. WO 2004050061.
   Google Scholar
• El-laithy HM, Hamza YE, Kandil SM. (2011). Design and hepatoprotective evaluation of biphenyl dimethyl dicarboxylate (DDB) and silymarin solid dispersion and self-micro emulsifying drug delivery systems. Life Sci J 8:298–310.
   Google Scholar
• Constantinides PP, Scalart JP, Lancaster C, Marcello J, Marks G, Ellens H et al. (1994). Formulation and intestinal absorption enhancement evaluation of water-in-oil microemulsions incorporating medium-chain glycerides. Pharm Res, 11:1385–1390.
   PubMed Web of Science ®Google Scholar
• Shah NH, Carvajal MT, Patel CI, Infeld MH, Malick AW. (1994). Self-emulsifying drug delivery system (SEDDS) with polyglycolized glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm 106:15–23.
   Web of Science ®Google Scholar
• Constantinides PP. (1995). Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res, 12:1561–1572.
   PubMed Web of Science ®Google Scholar
• Wasan KM. (2001). Formulation and physiological and biopharmaceutical issues in the development of oral lipid-based drug delivery systems. Drug Dev Ind Pharm, 27:267–276.
   PubMed Web of Science ®Google Scholar
• Kohli K, Chopra S, Dhar D, Arora S, Khar RK. (2010). Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability. Drug Discov Today, 15:958–965.
   PubMed Web of Science ®Google Scholar
• O’Driscoll CM, Griffin BT. (2008). Biopharmaceutical challenges associated with drugs with low aqueous solubility–the potential impact of lipid-based formulations. Adv Drug Deliv Rev, 60:617–624.
   PubMed Web of Science ®Google Scholar
• Attia IA, El-Gizawy SA, Fouda MA, Donia AM. (2007). Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits. AAPS PharmSciTech, 8:E106.
   PubMed Web of Science ®Google Scholar
• Zhang L, Chai G, Zeng X, He H, Xu H, Tang X. (2010). Preparation of fenofibrate immediate-release tablets involving wet grinding for improved bioavailability. Drug Dev Ind Pharm, 36:1054–1063.
   PubMed Web of Science ®Google Scholar
• Lu Y, Zhang T, Tao J, Ji G, Wang S. (2009). Preparation, characterization, and pharmacokinetics of the inclusion complex of genipin-beta-cyclodextrin. Drug Dev Ind Pharm, 35:1452–1459.
   PubMed Web of Science ®Google Scholar
• Boghra RJ, Kothawade PC, Belgamwar VS, Nerkar PP, Tekade AR, Surana SJ. (2011). Solubility, dissolution rate and bioavailability enhancement of irbesartan by solid dispersion technique. Chem Pharm Bull, 59:438–441.
   PubMed Web of Science ®Google Scholar
• He H, Yang R, Tang X. (2010). In vitro and in vivo evaluation of fenofibrate solid dispersion prepared by hot-melt extrusion. Drug Dev Ind Pharm, 36:681–687.
   PubMed Web of Science ®Google Scholar